NCT00004333已完成2 期
Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I
National Center for Research Resources (NCRR)0 个研究点开始时间: 1994年11月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
OBJECTIVES:
Assess whether 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) at 0.6 mg/kg per day prevents liver failure in at least 1 patient with tyrosinemia type I.
详细描述
PROTOCOL OUTLINE: Only 2 patients with tyrosinemia type I are known to this research team; others will be treated if found and if clinical conditions permit.
The enzyme inhibitor 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) is administered orally, in 2 divided doses daily with meals.
Patients will be followed closely for side effects attributable to NTBC.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 0 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •PROTOCOL ENTRY CRITERIA:
- •Tyrosinemia type I No cirrhosis No hepatocellular carcinoma
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Phase II clinical study of nab-PTX/CBDCA (administer 3-weeks on / 1-week off) for patients with clinical stage IIIB/IV or recurrent NSCLClung cancerJPRN-UMIN000016255Shiga University of Medical Science5
尚未招募
1 期
Investigations into a TNF inhibitor to limit complications following complex surgeryVascular surgerySurgery - Other surgeryACTRN12608000001392St.Vincent's Health Melbourne30
进行中（未招募）
2 期
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerLung Large Cell CarcinomaLung Non-Squamous Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Lung AdenocarcinomaNCT05198830National Cancer Institute (NCI)42
撤回
1 期
BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular CarcinomaHepato Cellular Carcinoma (HCC)NCT06608940Case Comprehensive Cancer Center43
终止
1 期
A Phase I Study of Nilontinib and Cetuximab in Patients With Solid TumorsHead and Neck CancerColorectal CancerNCT01871311Georgetown University15